What Is Annovis Bio, Inc. (ANVS) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Annovis Bio, Inc.'s intrinsic value is estimated at a composite fair value of $1.76. Trading at $1.81, the stock is approaching fair value or slight overvaluation (implied return of -3.0%), as 4 of 7 models suggest limited further upside. The most optimistic model, First Chicago, places fair value at $4.97 (+174.5%), while ML-RIV — the most conservative — estimates $0.03 (-98.1%). This +272.6% gap reflects genuine analytical uncertainty about Annovis Bio, Inc.'s intrinsic worth.
What Do the Models Say About ANVS?
7 of 13 models are currently active for ANVS. Of these, 2 models suggest upside while 5 models suggest overvaluation. The Bayesian DCF estimates ANVS's intrinsic value at $0.66, implying -63.3% downside from the current price. See which stocks rank higher →
How Does ANVS Rank in Biotechnology?
Among 76 Biotechnology stocks, ANVS ranks #57 by Quality of Company score. CirclFi's QOC score of 4.3/10 evaluates 32 fundamental signals. A score of 4.3 reflects mixed fundamentals.
See all Most Undervalued Biotechnology Stocks →
The Biotechnology sector introduces analytical considerations specific to biotech businesses. For Annovis Bio, Inc., metrics like clinical trial success rate provide important context that general-purpose valuation models may underweight.
Is ANVS a Value Trap?
CirclFi's Value Trap algorithm assigns ANVS a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for Annovis Bio, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Annovis Bio, Inc. scores 4.3 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +272.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ANVS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ANVS's 7 active models, average confidence is 19%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad